(44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged 81 пациенти), или диабет тип 2, когато тялото не може ефективно да произвежда инсулин (две проучвания, обхващащи 476 пациенти).
In most patients, Insulatard was compared with other types of human insulin or insulin analogues.